Skip to main content
Login
User menu
Mega menu
EASL
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - International Liver Congress
Industry Symposia - Liver Cancer Summit
Industry Symposia - NAFLD Summit 2022
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 891
(current)
Session 505
Displaying results 805 - 816 of 891
Display:
12
24
48
Cirrhosis & Complications
Tribute to Luigi Pagliaro
Webcasts
View
Cirrhosis & Complications
Discussion
Webcasts
View
Cirrhosis & Complications
Session 1 - Part 2: Noninvasive tools for cACLD and portal hypertension
Webcasts
View
Cirrhosis & Complications
Compensated Advanced Chronic Liver Disease (cACLD)
Webcasts
View
Cirrhosis & Complications
Use of noninvasive tools for prognosis in cirrhosis
Webcasts
View
Cirrhosis & Complications
CSPH
Webcasts
View
Cirrhosis & Complications
Screening for varices and the impact of the Baveno VI criteria
Webcasts
View
Cirrhosis & Complications
Welcome and introduction - Tribute to the Baveno Legends
Webcasts
View
Cirrhosis & Complications
Tribute to Tom Boyer
Webcasts
View
Cirrhosis & Complications
Tribute to Andy Burroughs
Webcasts
View
General Hepatology
EASL Studio Podcast S3 E8: Transplanting patients with cancer – Is there a limit?
EASL Studio
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S3 Special Edition: Ending fatty liver disease as a public health threat
Podcasts
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
64
Page
65
Page
66
Page
67
Current page
68
Page
69
Page
70
Page
71
Page
72
…
Next page
next ›
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy